BloodScan reveals tumor signals directly from a simple blood draw—empowering diagnosis even when traditional tissue biopsy fails.
From stage 0 to stage 4, BloodScan’s Labyrinth One system isolates intact circulating tumor cells (CTCs) directly from blood. For patients where tissue biopsy is unsafe, impractical, or impossible, we provide a safe, non-invasive, biopsy-equivalent alternative.
Learn More About Labyrinth One
BloodScan achieves near-100% capture of circulating tumor cells in stage IV breast, lung, pancreatic, and virtually all solid cancers—providing the most reliable tumor signal in advanced disease.
Our Labyrinth system uniquely identifies circulating tumor cells from the earliest stages—even in pre-invasive conditions such as DCIS and early HCC—reaching beyond the limits of traditional liquid biopsy.
BloodScan’s intact CTCs preserve real tumor biology, delivering tissue-equivalent genomic and treatment-relevant insights through a simple blood draw.
A standard blood draw into EDTA or other compatible vacutainer tubes.
Automated CTC isolation with Labyrinth One
Intact, viable cells ready for histology, genomics, and advanced assays